— Know what they know.
Not Investment Advice

GSAC OTC

GelStat Corporation
1W: -0.0% 1M: -0.0% 3M: +20.0% YTD: -14.3% 1Y: -14.3% 3Y: -25.0% 5Y: -96.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 50 · $185394 mcap · 530M float · 0.181% daily turnover · Short 22% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.000199999995-0.0005
Volume6,687,900
Avg Volume962,276
Beta1.64
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJavier G. Acosta
Employees2
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date1996-02-09
3557 SW Corporate Parkway
Palm City, FL 34990
US
772-283-0020
About GelStat Corporation

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Goldfarb Adrian Grah P-Purchase 9,843,750 $0.00 2022-02-04
Goldfarb Adrian Grah P-Purchase 8,000,000 $0.00 2022-02-04
Goldfarb Adrian Grah P-Purchase 16,000,000 $0.00 2022-02-04
Goldfarb Adrian Grah P-Purchase 53,209,459 $0.01 2022-02-04
Acosta Javier G 0 — 2022-02-04

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms